The relationship between DRD2 gene polymorphisms (C957T and C939T) and schizophrenia: A meta-analysis

被引:25
作者
Liu, Li [1 ]
Fan, Dazhi [1 ]
Ding, Ning [1 ]
Hu, Yanting [1 ]
Cai, Guoqi [1 ]
Wang, Li [1 ]
Xin, Lihong [1 ]
Xia, Qin [1 ]
Li, Xiaona [1 ]
Xu, Shengqian [2 ]
Xu, Jianhua [2 ]
Yang, Xiao [1 ]
Zou, Yanfeng [1 ]
Pan, Faming [1 ]
机构
[1] Anhui Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Hefei 230032, Anhui, Peoples R China
[2] Anhui Med Univ, Affiliated Hosp 1, Dept Rheumatism & Immun, Hefei 230022, Anhui, Peoples R China
基金
中国国家自然科学基金;
关键词
Schizophrenia; Dopamine D2 receptor; C957T; C939T; Polymorphisms; Meta-analysis; DOPAMINE D2 RECEPTOR; TARDIVE-DYSKINESIA; ASSOCIATION; SUSCEPTIBILITY; FALSE; RISK;
D O I
10.1016/j.neulet.2014.09.024
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Schizophrenia is a common, complex multi-factorial psychiatric disorder. Many studies have reported associations between the C957T and C939T polymorphisms in Dopamine D2 receptor (DRD2) gene and schizophrenia, but results are inconsistent. To derive a more precise estimation of the relationship, a meta-analysis was conducted to systematically summarize the possibility. We included 13 article's involving 3079 schizophrenia cases and 3851 healthy controls. Positive associations were found between C957T polymorphism and schizophrenia risk in C vs. T (OR = 1.26, 95% Cl = 1.09-1.46, P-raw = 0.002, P-FDR = 0.005) and CC+CT vs. TT (OR = 1.47, 95% CI = 1.25-1.73, P-raw < 0.001, P-FDR < 0.001). When stratified by race, a significantly increased risk of schizophrenia was observed in Caucasians, but not in Asians. No association between C939T polymorphism and schizophrenia was found in overall or Asian population. Our study suggested that C957T of DRD2 gene polymorphism is likely to be a risk factor for schizophrenia, especially in Caucasian. (C) 2014 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:43 / 48
页数:6
相关论文
共 43 条
[1]  
[Anonymous], BIOMETRICS, DOI DOI 10.2307/3001666
[2]  
[Anonymous], The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomized Studies in Meta- Analysis
[3]  
[Anonymous], ASS DOPAMINE D2 RECE
[4]   Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction [J].
Ayalew, M. ;
Le-Niculescu, H. ;
Levey, D. F. ;
Jain, N. ;
Changala, B. ;
Patel, S. D. ;
Winiger, E. ;
Breier, A. ;
Shekhar, A. ;
Amdur, R. ;
Koller, D. ;
Nurnberger, J. I. ;
Corvin, A. ;
Geyer, M. ;
Tsuang, M. T. ;
Salomon, D. ;
Schork, N. J. ;
Fanous, A. H. ;
O'Donovan, M. C. ;
Niculescu, A. B. .
MOLECULAR PSYCHIATRY, 2012, 17 (09) :887-905
[5]   CONTROLLING THE FALSE DISCOVERY RATE - A PRACTICAL AND POWERFUL APPROACH TO MULTIPLE TESTING [J].
BENJAMINI, Y ;
HOCHBERG, Y .
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY, 1995, 57 (01) :289-300
[6]   Case-control association study of 59 candidate genes reveals the DRD2 SNP rs6277 (C957T) as the only susceptibility factor for schizophrenia in the Bulgarian population [J].
Betcheva, Elitza T. ;
Mushiroda, Taisei ;
Takahashi, Atsushi ;
Kubo, Michiaki ;
Karachanak, Sena K. ;
Zaharieva, Irina T. ;
Vazharova, Radoslava V. ;
Dimova, Ivanka I. ;
Milanova, Vihra K. ;
Tolev, Todor ;
Kirov, George ;
Owen, Michael J. ;
O'Donovan, Michael C. ;
Kamatani, Naoyuki ;
Nakamura, Yusuke ;
Toncheva, Draga I. .
JOURNAL OF HUMAN GENETICS, 2009, 54 (02) :98-107
[7]  
Cho Ah Rang, 2012, Clin Psychopharmacol Neurosci, V10, P88, DOI 10.9758/cpn.2012.10.2.88
[8]   METAANALYSIS IN CLINICAL-TRIALS [J].
DERSIMONIAN, R ;
LAIRD, N .
CONTROLLED CLINICAL TRIALS, 1986, 7 (03) :177-188
[9]   Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor [J].
Duan, JB ;
Wainwright, MS ;
Comeron, JM ;
Saitou, N ;
Sanders, AR ;
Gelernter, J ;
Gejman, PV .
HUMAN MOLECULAR GENETICS, 2003, 12 (03) :205-216
[10]   A genetic schizophrenia-susceptibility region located between the ANKK1 and DRD2 genes [J].
Dubertret, Caroline ;
Bardel, Claire ;
Ramoz, Nicolas ;
Martin, Pierre-Marie ;
Deybach, Jean-Charles ;
Ades, Jean ;
Gorwood, Philip ;
Gouya, Laurent .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2010, 34 (03) :492-499